CHRONIC DISEASE;
COST EFFECTIVENESS ANALYSIS;
DIABETES MELLITUS;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH CARE SYSTEM;
HEALTH ECONOMICS;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
ISCHEMIC HEART DISEASE;
LETTER;
LIFESTYLE MODIFICATION;
MEDICAL PRACTICE;
PERSONNEL MANAGEMENT;
PRIORITY JOURNAL;
REIMBURSEMENT;
SOCIAL SUPPORT;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNITED STATES;
CORONARY DISEASE;
COST CONTROL;
HEALTH CARE REFORM;
HEALTH PROMOTION;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
LIFE STYLE;
UNITED STATES;
UNIVERSAL COVERAGE;
EID: 67649311624PISSN: 14702045EISSN: NoneSource Type: Journal DOI: 10.1016/S1470-2045(09)70175-5Document Type: Letter
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study)
Yusuf S., Hawken S., Ôunpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet 364 (2004) 937-952
Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention
Ornish D., Magbanua M.J., Weidner G., et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Nat Acad Sci USA 105 (2008) 8369-8374
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
Ornish D., Lin J., Daubenmier J., et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 9 (2008) 1048-1057
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
Diabetes Prevention Research Group
Diabetes Prevention Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403